Douglas Hanahan

Title: Douglas Hanahan: Innovating Cancer Treatment Through Targeted Therapeutics

Introduction

Douglas Hanahan, a prominent inventor based in San Francisco, CA, has made significant contributions to the field of cancer research through his innovative inventions. With a total of 10 patents, his work focuses primarily on targeting tumor lymphatics and improving therapeutic strategies for cancer treatment.

Latest Patents

Among his latest patents is the breakthrough invention titled "Lymphatic zip codes in tumors." This patent discloses compositions and methods focused on selectively targeting tumor lymphatics. Another significant patent addresses the development of molecules that selectively home to the vasculature of pre-malignant dysplastic lesions or malignancies. This invention provides a conjugate containing a therapeutic moiety linked to a homing peptide or peptidomimetic that specifically targets the vasculature of malignant skin and includes key amino acid sequences.

Career Highlights

Throughout his career, Douglas Hanahan has worked with prestigious institutions such as the University of California and the Sanford-Burnham Medical Research Institute. His work in these esteemed organizations has facilitated his advancement in cancer research and innovation.

Collaborations

Douglas has collaborated with other notable scientists in the field, including Erkki I Ruoslahti and Lianglin Zhang. These collaborations have helped to enhance the impact of his research and contribute to the development of groundbreaking cancer therapies.

Conclusion

Douglas Hanahan’s inventive spirit and dedication to improving cancer treatment through innovative research is evident in his numerous patents and collaborations. His work continues to inspire advancements in targeted therapeutics, promising better outcomes for patients facing malignancies.